Φορτώνει......
A Novel RXR Agonist, UAB30, Inhibits Rhabdomyosarcoma Cells in Vitro
BACKGROUND: While patients with early stage rhabdomyosarcoma (RMS) have seen steady improvement in prognosis over the last fifty years, those with advanced stage or high grade disease continue to have a dismal prognosis. Retinoids have been shown to cause growth suppression and terminal differentiat...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Surg Res |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007849/ https://ncbi.nlm.nih.gov/pubmed/29907230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jss.2018.02.057 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|